logo

For the Inventor, By the Inventor

Daegu, South Korea

Yong Min Chang

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal7 out of 336 
 
Kyungpook National University Industry-Academic Cooperation Foundation
 patents
silverMedal2 out of 2 
 
Etnova Therapeutics Corp.
 patents
bronzeMedal1 out of 832,843 
Other
 patents
where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12466843 - Gadolinium-based compound, method for producing same, and MRI contrast agent containing same (2025-11-11),
2. 12404255 - Compound and pharmaceutical composition containing same for treating or preventing neural damage, neural disease, or developmental disorder through promoting proliferation, differentiation, and/or regeneration of neural cells (2025-09-02),
3. 12370271 - Gadolinium-based compound, preparation method therefor, and MRI contrast agent containing same (2025-07-29),
4. 12098147 - Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drug (2024-09-24),
5. 11998619 - Compound, antiinflammatory drug comprising the compound and cyclooxygenase-2 inhibitor comprising the compound (2024-06-04),
6. 10759817 - Gadolinium complex, method for synthesis of the gadolinium complex, and MRI contrast agent including the gadolinium complex (2020-09-01),
7. 10245328 - Gadolinium complex comprising DO3A-tranexamic acid conjugate (2019-04-02),
8. 8901294 - MRI contrast agent having gadolinium complex (2014-12-02),
9. 8822697 - Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same (2014-09-02),

Title: Yong Min Chang: Innovator in Medical Chemistry

Introduction

Yong Min Chang is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of medical chemistry, particularly in the development of gadolinium-based compounds and their applications in MRI technology. With a total of 9 patents, his work has the potential to impact the diagnosis and treatment of various neural conditions.

Latest Patents

Chang's latest patents include a gadolinium-based compound, a method for producing the same, and an MRI contrast agent containing this compound. The invention relates to a gadolinium-based compound defined by a specific chemical formula, which includes linking groups and a Rose Bengal-derived part. Additionally, he has developed a compound and pharmaceutical composition aimed at treating or preventing neural damage, neural diseases, or developmental disorders. This compound may serve as a therapeutic agent for degenerative brain diseases, cognitive function improvement, and enhancing learning abilities.

Career Highlights

Throughout his career, Yong Min Chang has worked with notable institutions, including the Kyungpook National University Industry-Academic Cooperation Foundation and Etnova Therapeutics Corporation. His research has focused on innovative solutions to complex medical challenges, particularly in the realm of neural health.

Collaborations

Chang has collaborated with esteemed colleagues such as Tae-Jeong Kim and Yeoun Hee Kim. Their joint efforts have contributed to advancing research in medical chemistry and enhancing the efficacy of treatments for neural conditions.

Conclusion

Yong Min Chang's innovative work in the field of medical chemistry, particularly with gadolinium-based compounds, showcases his commitment to improving healthcare solutions. His contributions have the potential to significantly enhance the treatment of neural diseases and cognitive disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…